Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB
- 8 November 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 24 (3), 390-398
- https://doi.org/10.1038/sj.onc.1208192
Abstract
Arsenic trioxide (ATO) has been implicated as a promising anticancer agent by inhibiting cell growth and inducing apoptosis in certain types of cancer cells. This study explored the antimetastasis property of arsenic, drew potential link between arsenic use and radiotherapy, and uncovered the specific mechanisms underlying these remarkable responses. Using gelatin invasion assay and intravasation assay, we report the novel finding that low-dose ATO (1 μM) reduced the intrinsic migration ability of HeLa cells and significantly inhibited radiation-promoted tumor invasive potential of CaSki cells without inducing apoptotic cell death. Using the murine Lewis lung carcinoma model, the control animals and ATO treatment animals (1 mg/kg i.p., twice weekly) displayed similar in vivo growth kinetics, whereas the radiation (30 Gy in one fraction) and concurrent treatment groups showed considerable growth inhibition. Importantly, although concurrent treatment did not enhance the effectiveness of radiation therapy to the primary tumor, further examination of the lungs revealed that all animals succumbed to radiation-accelerated lung metastases could be effectively treated by combination of ATO and radiation. Radiation-induced matrix metalloproteinase-9 (MMP-9) expression was significantly inhibited by ATO using sequential analysis of the expression of MMPs in xenografts. Supporting this observation, ATO directly downregulates radiation-induced MMP-9 mRNA expression by inhibiting nuclear factor κB activity in human cervical cancer cells. In sum, concurrent arsenic–radiation therapy not only achieves local tumor control but also inhibits distant metastasis. Experimental results of this study highlight a novel strategy in cancer treatment.Keywords
This publication has 45 references indexed in Scilit:
- Inhibition of NF-κB essentially contributes to arsenic-induced apoptosisBlood, 2003
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cellsInternational Journal of Radiation Biology, 2002
- The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathwayOncogene, 2001
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Enhanced radiosensitivity by inhibition of nuclear factor kappaB activation in human malignant glioma cellsInternational Journal of Radiation Biology, 1997
- Radiosensitizing NucleosidesJNCI Journal of the National Cancer Institute, 1996